← All companies

GERN Geron Corp

PHARMACEUTICAL PREPARATIONS · $777M market cap · updated 2026-10-06
Market price
$1.21
Avg intrinsic value
$0.00
Margin of safety
—

Three independent discounted-cash-flow-style models value Geron Corp every trading day. 0 of 3 currently price GERN above its market price.

Model estimates

Free Cash Flow model$-11,512.27
Excess Profit model$-6,840.95
Residual Earnings model$-0.02
Dividend Discount model—

Quality snapshot

Piotroski F-Score1 / 9
Return on invested capital-18.2%
Net debt / EBITDA—
Gross margin+100.0%
Revenue CAGR+575.7%
Cash conversion—
Dividend yield—
Buyback yield-3.2%

Run your own numbers

These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.

Open GERN in StockKitty

Same sector